Brain tumour patients and COVID-19 vaccines IBTA international survey
Brain tumour patients and COVID-19 vaccines
IBTA international survey
The International Brain Tumour Alliance (IBTA) is running a new survey on COVID-19 vaccines and brain tumour patients. The survey is for people over the age of 18 who have been diagnosed with any type of brain tumour (including metastatic brain tumours). The survey will collect data anonymously on, for example, how the coronavirus vaccination programmes in different countries have been offered to brain tumour patients; COVID-19 testing; which vaccines brain tumour patients have received; and vaccine side effects in brain tumour patients, etc.
The survey is available in eight languages (English, French, German, Italian, Japanese, Polish, Spanish and Urdu) and typically takes no more than ten minutes to complete. The deadline for submitting survey responses is 31st August 2021.
Sharing the survey: the direct links for all languages are below:
English: https://www.research.net/r/IBTACOVIDVAXFrench: https://www.research.net/r/IBTACOVIDVAX?lang=fr
German: https://www.research.net/r/IBTACOVIDVAX?lang=de
Italian: https://www.research.net/r/IBTACOVIDVAX?lang=it
Japanese: https://www.research.net/r/IBTACOVIDVAX?lang=ja
Polish: https://www.research.net/r/IBTACOVIDVAX?lang=pl
Spanish: https://www.research.net/r/IBTACOVIDVAX?lang=es
Urdu: https://www.research.net/r/IBTACOVIDVAX-ur (Please note that the Urdu survey can only be accessed via this link.)
QR codes: The QR code for the various language versions of the survey can be downloaded from the IBTA website here. A separate QR code for the Urdu translation can be found here.